Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AVITA Medical (RCEL) Accumulated Expenses (2019 - 2025)

AVITA Medical's Accumulated Expenses history spans 7 years, with the latest figure at $7.8 million for Q4 2025.

  • For Q4 2025, Accumulated Expenses fell 25.24% year-over-year to $7.8 million; the TTM value through Dec 2025 reached $7.8 million, down 25.24%, while the annual FY2025 figure was $7.8 million, 25.24% down from the prior year.
  • Accumulated Expenses reached $7.8 million in Q4 2025 per RCEL's latest filing, up from $5.8 million in the prior quarter.
  • In the past five years, Accumulated Expenses ranged from a high of $10.5 million in Q4 2024 to a low of $2.5 million in Q1 2021.
  • Average Accumulated Expenses over 5 years is $6.1 million, with a median of $6.0 million recorded in 2023.
  • Peak YoY movement for Accumulated Expenses: surged 58.34% in 2024, then plummeted 40.72% in 2025.
  • A 5-year view of Accumulated Expenses shows it stood at $5.4 million in 2021, then rose by 23.49% to $6.6 million in 2022, then rose by 20.37% to $8.0 million in 2023, then surged by 31.1% to $10.5 million in 2024, then decreased by 25.24% to $7.8 million in 2025.
  • Per Business Quant, the three most recent readings for RCEL's Accumulated Expenses are $7.8 million (Q4 2025), $5.8 million (Q3 2025), and $7.9 million (Q2 2025).